| Category | BioTech |
| Employees |
| TOTAL | $54M |
| FUNDING TOTAL | $54M |
| Series A, 10/11 U.S. Venture Partners 5AM Ventures Clarus Ventures OrbiMed Advisors Astellas Venture Management | $44M |
| Series A, 4/13 New Enterprise Associates | $10M |
Cleave Biosciences, a Burlingame, California-based newly established biopharmaceutical company discovering and developing novel therapies for cancer.
